Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells. [electronic resource]
Producer: 20180717Description: 965-975 p. digitalISSN:- 1432-1440
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Disease Models, Animal
- Docetaxel
- Drug Synergism
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Mice
- Phenyl Ethers -- pharmacology
- Phenylurea Compounds -- pharmacology
- Prognosis
- Protein Tyrosine Phosphatase, Non-Receptor Type 6 -- genetics
- STAT3 Transcription Factor -- metabolism
- Signal Transduction -- drug effects
- Taxoids -- pharmacology
- Transcription, Genetic
- Triple Negative Breast Neoplasms -- genetics
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.